Literature DB >> 22412620

2,4-Dichloro-7-fluoro-quinazoline.

Feng Gao1, Yun-Fei Hu, Jin-Long Wang.   

Abstract

The mol-ecule of the title compound, C(8)H(3)Cl(2)FN(2), is essentially planar, with a maximum deviation of 0.018 (2) Å. In the crystal, π-π stacking is observed between parallel quinazoline moieties of adjacent mol-ecules, the centroid-centroid distance being 3.8476 (14) Å.

Entities:  

Year:  2012        PMID: 22412620      PMCID: PMC3295509          DOI: 10.1107/S1600536812006125

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the synthesis of quinazoline derivatives, see: Roberts et al. (2011 ▶); Gao et al. (2010 ▶); Li et al. (2009 ▶); Connolly et al. (2005 ▶). For the pharmacological properties of quinazoline analogues, see: Koller et al. (2011 ▶); Garofalo et al. (2011 ▶); Yang et al. (2011 ▶). For related structures, see: Jia et al. (2011 ▶); Ouahrouch et al. (2011 ▶).

Experimental

Crystal data

C8H3Cl2FN2 M = 217.02 Monoclinic, a = 3.8257 (3) Å b = 15.0664 (9) Å c = 14.3453 (6) Å β = 95.102 (5)° V = 823.59 (9) Å3 Z = 4 Mo Kα radiation μ = 0.75 mm−1 T = 293 K 0.35 × 0.30 × 0.25 mm

Data collection

Agilent Xcalibur Eos diffractometer Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2010 ▶) T min = 0.780, T max = 0.835 3156 measured reflections 1452 independent reflections 1120 reflections with I > 2σ(I) R int = 0.025

Refinement

R[F 2 > 2σ(F 2)] = 0.038 wR(F 2) = 0.095 S = 1.07 1452 reflections 118 parameters H-atom parameters constrained Δρmax = 0.20 e Å−3 Δρmin = −0.23 e Å−3 Data collection: CrysAlis PRO (Agilent, 2010 ▶); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SHELXTL (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL. Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S1600536812006125/xu5446sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536812006125/xu5446Isup2.hkl Supplementary material file. DOI: 10.1107/S1600536812006125/xu5446Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C8H3Cl2FN2F(000) = 432
Mr = 217.02Dx = 1.750 Mg m3
Monoclinic, P21/nMo Kα radiation, λ = 0.71073 Å
a = 3.8257 (3) ÅCell parameters from 1033 reflections
b = 15.0664 (9) Åθ = 3.0–25.0°
c = 14.3453 (6) ŵ = 0.75 mm1
β = 95.102 (5)°T = 293 K
V = 823.59 (9) Å3Block, brown
Z = 40.35 × 0.30 × 0.25 mm
Agilent Xcalibur Eos diffractometer1452 independent reflections
Radiation source: Enhance (Mo) X-ray Source1120 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.025
Detector resolution: 10.0 pixels mm-1θmax = 25.0°, θmin = 3.1°
ω scansh = −4→4
Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2010)k = −15→17
Tmin = 0.780, Tmax = 0.835l = −16→16
3156 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.038Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.095H-atom parameters constrained
S = 1.07w = 1/[σ2(Fo2) + (0.0389P)2] where P = (Fo2 + 2Fc2)/3
1452 reflections(Δ/σ)max < 0.001
118 parametersΔρmax = 0.20 e Å3
0 restraintsΔρmin = −0.23 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
Cl10.18763 (19)0.24582 (4)0.86579 (4)0.0500 (3)
Cl20.2734 (2)0.09054 (5)0.54819 (5)0.0628 (3)
F10.8584 (4)0.55046 (10)0.60324 (11)0.0652 (5)
N10.2491 (5)0.17987 (14)0.70176 (14)0.0416 (5)
N20.4812 (5)0.25290 (13)0.57255 (14)0.0389 (5)
C10.3448 (6)0.18701 (17)0.61375 (17)0.0392 (6)
C20.3050 (6)0.25134 (16)0.75263 (17)0.0360 (6)
C30.4494 (6)0.33043 (16)0.72000 (16)0.0331 (6)
C40.5323 (6)0.32793 (16)0.62626 (16)0.0327 (6)
C50.6758 (7)0.40354 (16)0.58670 (16)0.0389 (6)
H50.73650.40300.52530.047*
C60.7228 (7)0.47677 (17)0.64004 (19)0.0428 (7)
C70.6403 (7)0.48233 (17)0.73259 (19)0.0455 (7)
H70.67830.53460.76650.055*
C80.5030 (7)0.40973 (16)0.77230 (17)0.0426 (7)
H80.44430.41220.83380.051*
U11U22U33U12U13U23
Cl10.0595 (5)0.0612 (5)0.0313 (4)0.0047 (4)0.0158 (3)0.0092 (3)
Cl20.0870 (6)0.0476 (5)0.0541 (5)−0.0111 (4)0.0086 (4)−0.0150 (4)
F10.0783 (13)0.0466 (10)0.0717 (12)−0.0159 (9)0.0123 (10)0.0132 (9)
N10.0454 (14)0.0428 (13)0.0367 (12)−0.0035 (11)0.0043 (10)0.0014 (11)
N20.0455 (13)0.0404 (13)0.0314 (11)−0.0004 (11)0.0074 (10)−0.0032 (10)
C10.0433 (16)0.0373 (15)0.0369 (14)0.0015 (13)0.0029 (12)−0.0033 (12)
C20.0330 (14)0.0469 (16)0.0285 (12)0.0071 (12)0.0045 (11)0.0052 (12)
C30.0320 (14)0.0385 (14)0.0286 (12)0.0057 (12)0.0022 (11)0.0039 (11)
C40.0301 (14)0.0365 (14)0.0315 (13)0.0033 (12)0.0019 (11)0.0037 (11)
C50.0427 (16)0.0437 (16)0.0311 (13)0.0022 (13)0.0074 (12)0.0037 (12)
C60.0389 (15)0.0397 (16)0.0493 (16)−0.0033 (13)0.0008 (13)0.0123 (14)
C70.0504 (17)0.0370 (15)0.0485 (16)0.0004 (13)0.0013 (13)−0.0069 (13)
C80.0469 (17)0.0478 (16)0.0336 (14)0.0060 (14)0.0066 (12)−0.0037 (13)
Cl1—C21.724 (2)C3—C81.416 (3)
Cl2—C11.739 (3)C4—C51.406 (3)
F1—C61.352 (3)C5—C61.346 (3)
N1—C21.308 (3)C5—H50.9300
N1—C11.350 (3)C6—C71.394 (4)
N2—C11.289 (3)C7—C81.360 (3)
N2—C41.372 (3)C7—H70.9300
C2—C31.411 (3)C8—H80.9300
C3—C41.409 (3)
C2—N1—C1114.3 (2)C5—C4—C3119.5 (2)
C1—N2—C4114.9 (2)C6—C5—C4118.2 (2)
N2—C1—N1130.1 (2)C6—C5—H5120.9
N2—C1—Cl2116.50 (18)C4—C5—H5120.9
N1—C1—Cl2113.36 (19)C5—C6—F1119.2 (2)
N1—C2—C3124.0 (2)C5—C6—C7124.1 (2)
N1—C2—Cl1116.25 (18)F1—C6—C7116.7 (2)
C3—C2—Cl1119.70 (18)C8—C7—C6118.6 (2)
C4—C3—C2115.0 (2)C8—C7—H7120.7
C4—C3—C8119.6 (2)C6—C7—H7120.7
C2—C3—C8125.4 (2)C7—C8—C3120.0 (2)
N2—C4—C5118.8 (2)C7—C8—H8120.0
N2—C4—C3121.7 (2)C3—C8—H8120.0
  7 in total

1.  Virtual screening and synthesis of quinazolines as novel JAK2 inhibitors.

Authors:  Su Hui Yang; Daulat Bikram Khadka; Suk Hee Cho; Hye-Kyung Ju; Kwang Youl Lee; Ho Jae Han; Kyung-Tae Lee; Won-Jea Cho
Journal:  Bioorg Med Chem       Date:  2010-11-30       Impact factor: 3.641

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  Quinazolinedione sulfonamides: a novel class of competitive AMPA receptor antagonists with oral activity.

Authors:  Manuel Koller; Kurt Lingenhoehl; Markus Schmutz; Ivan-Toma Vranesic; Joerg Kallen; Yves P Auberson; David A Carcache; Henri Mattes; Silvio Ofner; David Orain; Stephan Urwyler
Journal:  Bioorg Med Chem Lett       Date:  2011-04-08       Impact factor: 2.823

4.  Impact of aryloxy-linked quinazolines: a novel series of selective VEGFR-2 receptor tyrosine kinase inhibitors.

Authors:  Antonio Garofalo; Laurence Goossens; Perrine Six; Amélie Lemoine; Séverine Ravez; Amaury Farce; Patrick Depreux
Journal:  Bioorg Med Chem Lett       Date:  2011-02-03       Impact factor: 2.823

5.  A new and facile synthesis of quinazoline-2,4(1H,3H)-diones.

Authors:  Jiarong Li; Xian Chen; Daxin Shi; Shuling Ma; Qing Li; Qi Zhang; Jianhong Tang
Journal:  Org Lett       Date:  2009-03-19       Impact factor: 6.005

6.  4-[(7-Fluoro-quinazolin-4-yl)-oxy]aniline.

Authors:  Jing Jia; Guibin Wang; Dingqiang Lu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-12-24

7.  4-(4-{[(2-Phenyl-quinazolin-4-yl)-oxy]methyl}-1H-1,2,3-triazol-1-yl)butan-1-ol hemihydrate.

Authors:  Abdelaaziz Ouahrouch; Hassan B Lazrek; Moha Taourirte; Mohamed El Azhari; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-07-13
  7 in total
  1 in total

1.  Crystal structure of 4-meth-oxy-quinazoline.

Authors:  Gamal A El-Hiti; Keith Smith; Amany S Hegazy; Mohammed B Alshammari; Benson M Kariuki
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-11-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.